Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 435, 1159 (30 June 2005) | doi:10.1038/4351159b; Published online 29 June 2005
In brief
The New York-based, non-profit International AIDS Vaccine Initiative (IAVI) is to partner pharmaceutical giant GlaxoSmithKline in an effort to develop an AIDS vaccine.The partners say they will pursue a vaccine based on an adenovirus, which is stripped of its infectious genes, focusing on those that naturally infect chimpanzees.
To read this story in full you will need to login or make a payment (see right).